Wells Fargo & Company Medpace Holdings, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 33,162 shares of MEDP stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,162

Previous 46,156 28.15%

Holding current value

$11.6 Million

Previous $19 Million 41.82%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$320.58 - $457.29 $4.17 Million - $5.94 Million	-12,994 Reduced 28.15%	33,162 $11.1 Million
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $1.84 Million - $2.1 Million	4,958 Added 12.03%	46,156 $19 Million
Q1 2024 May 10, 2024	SELL	$284.87 - $413.31 $1.98 Million - $2.88 Million	-6,960 Reduced 14.45%	41,198 $16.7 Million
Q4 2023 Feb 09, 2024	SELL	$227.52 - $312.68 $101,928 - $140,080	-448 Reduced 0.92%	48,158 $14.8 Million
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $9.31 Million - $11.2 Million	-39,802 Reduced 45.02%	48,606 $11.8 Million
Q2 2023 Aug 15, 2023	SELL	$187.26 - $240.17 $4.31 Million - $5.53 Million	-23,033 Reduced 20.67%	88,408 $21.2 Million
Q1 2023 May 12, 2023	SELL	$174.31 - $239.52 $2.75 Million - $3.78 Million	-15,771 Reduced 12.4%	111,441 $21 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $4.22 Million - $6.24 Million	-27,557 Reduced 17.81%	127,212 $27 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $1.25 Million - $1.57 Million	-8,616 Reduced 5.27%	154,769 $24.3 Million
Q2 2022 Aug 12, 2022	BUY	$130.2 - $168.03 $9.59 Million - $12.4 Million	73,633 Added 82.04%	163,385 $24.5 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $685,045 - $1.06 Million	-4,933 Reduced 5.21%	89,752 $14.7 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $3.81 Million - $4.75 Million	-20,858 Reduced 18.05%	94,685 $20.6 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $478,035 - $556,771	-2,809 Reduced 2.37%	115,543 $21.9 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $3.51 Million - $4.3 Million	-22,146 Reduced 15.76%	118,352 $20.9 Million
Q1 2021 May 13, 2021	SELL	$132.02 - $168.26 $3.06 Million - $3.9 Million	-23,165 Reduced 14.15%	140,498 $23 Million
Q4 2020 Feb 09, 2021	BUY	$109.38 - $149.19 $2.69 Million - $3.67 Million	24,633 Added 17.72%	163,663 $22.8 Million
Q3 2020 Nov 05, 2020	SELL	$92.95 - $130.61 $185,156 - $260,175	-1,992 Reduced 1.41%	139,030 $15.5 Million
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $173,808 - $244,271	-2,553 Reduced 1.78%	141,022 $13.1 Million
Q1 2020 May 14, 2020	BUY	$61.71 - $101.95 $8.86 Million - $14.6 Million	143,575 New	143,575 $10.5 Million

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Medpace Holdings, Inc. Transaction History